Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / *W EXP 09/01/203
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
2,795,078
-
Shares change
-
+89,660
-
Total reported value, excl. options
-
$2,186,394
-
Value change
-
+$67,244
-
Number of buys
-
2
-
Number of sells
-
4
-
Price
-
$0.7500
Institutional Holders of Oaktree Acquisition Corp. III Life Sciences - *W EXP 09/01/203 (OACCW) as of Q3 2025
As of 30 Sep 2025 Oaktree Acquisition Corp. III Life Sciences - *W EXP 09/01/203 (OACCW) had 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,795,078 shares of stock of the company.
Largest 10 holders included AQR Arbitrage LLC, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, Decagon Asset Management LLP, Driehaus Capital Management LLC, Walleye Capital LLC, Boussard & Gavaudan Investment Management LLP, JPMORGAN CHASE & CO, Linden Advisors LP, Shaolin Capital Management LLC, and MOORE CAPITAL MANAGEMENT, LP.
This table shows 28 institutional shareholders of the security as of 30 Sep 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.